Market Overview:
The global cell cycle analysis market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for cell cycle analysis products in research and diagnostics applications, and technological advancements in cell cycle analysis products. Based on type, the global cell cycle analysis market is segmented into software, instruments, consumables, and others. The software segment is expected to grow at a CAGR of 11.5% from 2018 to 2030 due to the increasing demand for software-based solutions for accurate data interpretation in research applications. Based on application, the global cell cycle analysis market is divided into diagnostics, research, therapeutics, and others segments.
Product Definition:
Cell cycle analysis is the process of measuring and quantifying the DNA content of cells at different stages in the cell cycle. This information can be used to determine how a particular gene is expressed throughout the cell cycle, and to identify genes that are involved in regulating the cell cycle.
Software:
Software is the part of a system that enables the analysis and manipulation of data. In cell cycle analysis market, software is used for various purposes such as to analyze &modify data, generate graphs & charts from results obtained from different tests and also helps in analyzing experimental results. Software plays an important role in Cell Cycle Analysis (CCA) industry owing to its ability to provide accurate &efficient solutions for various research problems related to cell cycle control.
Instruments:
Instruments and it's usage in cell cycle analysis market is used for measuring the size of a cell. Cell cycle analysis is done by observing the changes that take place in a cell from one phase to another. The different steps involved are division, migration, and death of cells. Dividing cells move towards the poles whereas migrating cells travel along anastomosis (a tube like structure) formed by intercellular bridges between two neighboring cells.
Application Insights:
The diagnosis segment dominated the global market in 2017. This is due to the rising prevalence of cancer and increasing government funding for cancer research. For instance, as per the statistics published by WHO in 2018, around 1.7 million people died due to cancer worldwide. Moreover, according to a study conducted by NCBI in 2019, it was estimated that around 5-10% of all cancers could be attributed to genetic mutations caused due to chromosomal aberrations (CA). Therefore, cell cycle analysis is used for tumor diagnostics and screening of susceptibility/resistance towards drugs using cell line models or patient samples with known outcomes such as response & resistance rates & survival probabilities among others which further boosts product demand globally.
Cell cycle analysis has wide applications such as drug discovery & development (R&D), biomarker discovery & validation, epigenetic studies etcetera which further drives its growth over the forecast period globally owing to increasing private.
Regional Analysis:
North America dominated the global market in 2017. Key factors contributing to its growth include a rise in the number of clinical trials, an increase in healthcare expenditure, and an increase in FDA approvals for new technologies. In addition, increasing research activities on cancer are expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to various factors such as rising disposable income and investments by governments for building advanced healthcare infrastructure coupled with growing awareness regarding early diagnosis of diseases & disorders among people living in this region. Moreover, a large population base suffering from chronic diseases is also driving this regional market demand over the forecast period.
Growth Factors:
- Increasing demand for personalized medicines
- Rising prevalence of cancer and other diseases
- Technological advancements in cell cycle analysis instruments and software
- Growing number of research studies on cell cycle analysis
- Increasing funding for cell cycle analysis research
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell Cycle Analysis Market Research Report
By Type
Software, Instruments, Consumables, Others
By Application
Diagnosis, Research, Therapeutics, Others
By Companies
Agilent Technologies, Merck KGAA, Affymetrix, Danaher Corporation, Olympus Corporation, GE Healthcare, Miltenyi Biotech, PerkinElmer, Nexcelom Bioscience, Dickinson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
122
Number of Tables & Figures
86
Customization Available
Yes, the report can be customized as per your need.
Global Cell Cycle Analysis Market Report Segments:
The global Cell Cycle Analysis market is segmented on the basis of:
Types
Software, Instruments, Consumables, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnosis, Research, Therapeutics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies
- Merck KGAA
- Affymetrix
- Danaher Corporation
- Olympus Corporation
- GE Healthcare
- Miltenyi Biotech
- PerkinElmer
- Nexcelom Bioscience
- Dickinson
Highlights of The Cell Cycle Analysis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Software
- Instruments
- Consumables
- Others
- By Application:
- Diagnosis
- Research
- Therapeutics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell Cycle Analysis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell cycle analysis is a laboratory technique used to study the cell division process in living cells. Cell cycle analysis can be used to identify the stages of the cell division process, and to determine how cells are affected by various treatments or diseases.
Some of the major players in the cell cycle analysis market are Agilent Technologies, Merck KGAA, Affymetrix, Danaher Corporation, Olympus Corporation, GE Healthcare, Miltenyi Biotech, PerkinElmer, Nexcelom Bioscience, Dickinson.
The cell cycle analysis market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell Cycle Analysis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cell Cycle Analysis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cell Cycle Analysis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cell Cycle Analysis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cell Cycle Analysis Market Size & Forecast, 2020-2028
4.5.1 Cell Cycle Analysis Market Size and Y-o-Y Growth
4.5.2 Cell Cycle Analysis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Software
5.2.2 Instruments
5.2.3 Consumables
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diagnosis
6.2.2 Research
6.2.3 Therapeutics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cell Cycle Analysis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cell Cycle Analysis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Software
9.6.2 Instruments
9.6.3 Consumables
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diagnosis
9.10.2 Research
9.10.3 Therapeutics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Software
10.6.2 Instruments
10.6.3 Consumables
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diagnosis
10.10.2 Research
10.10.3 Therapeutics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Software
11.6.2 Instruments
11.6.3 Consumables
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diagnosis
11.10.2 Research
11.10.3 Therapeutics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Software
12.6.2 Instruments
12.6.3 Consumables
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diagnosis
12.10.2 Research
12.10.3 Therapeutics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Software
13.6.2 Instruments
13.6.3 Consumables
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diagnosis
13.10.2 Research
13.10.3 Therapeutics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cell Cycle Analysis Market: Competitive Dashboard
14.2 Global Cell Cycle Analysis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Agilent Technologies
14.3.2 Merck KGAA
14.3.3 Affymetrix
14.3.4 Danaher Corporation
14.3.5 Olympus Corporation
14.3.6 GE Healthcare
14.3.7 Miltenyi Biotech
14.3.8 PerkinElmer
14.3.9 Nexcelom Bioscience
14.3.10 Dickinson
